WILLIAM E. ROTE
CIK 1698262 · Chief Research Officer · last filed 2026-05-06
WILLIAM E. ROTE is a Chief Research Officer who has filed 47 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for TVTX, was dated May 6, 2026. Across all open-market trades the lifetime net is −$5.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.15M
2
47
-$5.22M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TVTX | Chief Research Officer | 118,237 | $52.04 | $6.15M | -$4.65M | 28 | 2026-05-06 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Senior Vice President, R&D | 24,086 | — | — | -$567.0K | 19 | 2020-11-17 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-06 | TVTX | Mixed | +1,487 | -$121.4K | EDGAR |
| 2026-04-23 | TVTX | Sell (S) | −9,100 | -$355.7K | EDGAR |
| 2026-04-15 | TVTX | Grant (A) | +14,000 | $0 | EDGAR |
| 2026-02-03 | TVTX | Mixed | +7,644 | -$409.1K | EDGAR |
| 2025-12-29 | TVTX | Mixed | — | -$1.17M | EDGAR |
| 2025-05-05 | TVTX | Mixed | +1,722 | -$67.3K | EDGAR |
| 2025-02-12 | TVTX | Mixed | +2,800 | -$122.4K | EDGAR |
| 2025-02-04 | TVTX | Mixed | +12,549 | -$177.1K | EDGAR |
| 2025-01-23 | TVTX | Sell (S) | −2,437 | -$47.4K | EDGAR |
| 2024-09-09 | TVTX | Mixed | +2,363 | -$50.5K | EDGAR |